Hepatitis, Chronic: all 829 studies
Page 8 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedNCT00798460Phase 4
- Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)CompletedNCT00788918Not applicable
- Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV InfectionCompletedNCT00782353Phase 1
- Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedNCT00781105Phase 4
- Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis CCompletedNCT00778843Phase 3
- Prednisolone Priming Study in Patients With Chronic Hepatitis BStatus unknownNCT00778596Phase 4
- Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic InsufficiencyCompletedNCT00771446Phase 1/2
- 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis CCompletedNCT00763568Phase 2
- Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C PatientsCompletedNCT00759200Phase 2
- Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical TherapyCompletedNCT00749138Phase 1
- Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C PatientsCompletedNCT00724776Phase 1
- Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B PatientsWithdrawnNCT00715715Not applicable
- HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C PatientsStatus unknownNCT00703872Phase 2
- NIDDM and IR in Combination Therapy for CHCCompletedNCT00687999Not applicable
- Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral TreatmentCompletedNCT00680342Phase 2
- Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 PatientsCompletedNCT00680173Phase 4
- High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4TerminatedNCT00662220Phase 3
- A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3CompletedNCT00656006Phase 2
- CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation StudyCompletedNCT00645736
- Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and RibavirinTerminatedNCT00641654Phase 4
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedNCT00641082Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaCompletedNCT00630084Phase 4
- A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 PatientsCompletedNCT00629967Phase 4
- Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis CCompletedNCT00629824Phase 4
- Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCVStatus unknownNCT00611819Phase 4
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnNCT00606099Phase 4
- Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
- Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled TrialCompletedNCT00596414Phase 4
- Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase LevelsStatus unknownNCT00575627Phase 4
- Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsWithdrawnNCT00571714Not applicable
- Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedNCT00558493Phase 4
- Treatment Insulin Resistence in HCV G-1 PatientCompletedNCT00546442Phase 4
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis CCompletedNCT00540345Phase 4
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRCompletedNCT00532701Phase 4
- Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis BCompletedNCT00531167Phase 4
- Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous TherapiesCompletedNCT00530972Phase 4
- Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior TreatmentCompletedNCT00519792Phase 1
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedNCT00513968Phase 1
- Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusCompletedNCT00503347Phase 1
- Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4CompletedNCT00502099Phase 4
- Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.CompletedNCT00502086Phase 3
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
- Fluvastatin, Rosuvastatin Added to Pegylated Interferon and RibavirinCompletedNCT00487318Phase 2
- RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of RibavirinStatus unknownNCT00485342Phase 3
- An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00467545Phase 4
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Phase I Hepatitis C Vaccine Trial of Virosome-formulated PeptidesCompletedNCT00445419Phase 1
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CCompletedNCT00421434Phase 2/3
- Study of Nitazoxanide in the Treatment of Chronic Hepatitis CCompletedNCT00418639Phase 2
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3CompletedNCT00411385Phase 3
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNCT00402428Phase 3
- Study to Evaluate Drug-drug Interaction Between Valopicitabine and RibavirinCompletedNCT00395421Phase 2
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceStatus unknownNCT00370617Phase 4
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
- Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C InfectionCompletedNCT00352235Phase 1/2
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis CCompletedNCT00322179
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral MedicationTerminatedNCT00296972Phase 3
- Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis BCompletedNCT00291616Phase 4
- Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)CompletedNCT00287235Not applicable
- Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4CompletedNCT00277862Phase 4
- Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B InfectionCompletedNCT00277576Phase 1
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNCT00277238Phase 2
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.CompletedNCT00263614
- Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis CCompletedNCT00262379Phase 3
- A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedNCT00249860Phase 3
- Trial of Pegasys® in Patients With Chronic Hepatitis CCompletedNCT00245414Phase 4
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedNCT00230958Phase 3
- Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and RibavirinCompletedNCT00230854Phase 1
- Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis CCompletedNCT00227435Phase 1/2
- Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
- Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNCT00226382Phase 4
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected PatientsTerminatedNCT00221286Phase 3
- PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonCompletedNCT00215891Phase 3
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNCT00215865Phase 3
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon TherapyStatus unknownNCT00215839Phase 3
- Hepatitis C Treatment of InmatesTerminatedNCT00209898Phase 4
- Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis CTerminatedNCT00209755Not applicable
- Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2aCompletedNCT00199732
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
- Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsCompletedNCT00196586Phase 2
- Natural History of Hepatitis C in Patients With Normal Liver TestsCompletedNCT00187473
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00162734Phase 3
- Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)CompletedNCT00158496Phase 3